Navigation Links
Henry Ford Hospital first in United States to offer MKTP surgery as treatment option for vitiligo
Date:10/25/2011

DETROIT Henry Ford Hospital is the first in the country to offer skin transplant surgery as part of its treatment portfolio for patients with the skin disease vitiligo.

The surgery, known as melanocyte-keratinocyte transplantation or MKTP, involves using skin cells taken from normally pigmented areas of the body and transferring them to the damaged area of skin to restore pigmentation. It is performed under local anesthesia as an outpatient procedure.

Patients who underwent the surgery as part of a 2010 research study at Henry Ford achieved striking results.

MKTP is a promising treatment option for vitiligo, which causes the skin to lose color and develop white patches that vary in size and location. It affects about one in every 200 people in the United States, and is more noticeable in people with darker skin. The late Michael Jackson and actor Jon Hamm of Mad Men are two notable celebrities to have vitiligo.

Henry Ford senior staff dermatologist Iltefat Hamzavi, M.D., says MKTP may be the most effective treatment to date for a segment of the more than 2 million patients living with vitiligo and the emotional side effects that accompany it.

"MKTP gives new hope to these patients," Dr. Hamzavi says. "First, it restores pigmentation to the skin; second, it gives patients' self-confidence a boost."

"You no longer have to be self-conscious about it," says Adil Siddiqui, 23, an electrical engineer and a resident of Canton who underwent MKTP for restoring pigment to patches around his lips. A topical cream initially prescribed had modest effectiveness.

MKTP is offered at Henry Ford's Vitiligo Treatment Center, which is part of the Multicultural Dermatology Clinic in the Department of Dermatology. Patients may call 313-916-1618 to make an appointment or visit http://www.henryford.com/vitiligo for more information.

Currently, the procedure is not covered by insurance and the cost is dependent on the size of the treatment area. For an area less than 25 cubic centimeters, or about less than one inch by one inch, the cost is $3,500. Cost for an area of 25-100 cubic centimeters is $4,000. Cost includes the procedure, office visits and post-surgical dressings.

Dr. Hamzavi is among three board-certified dermatologists trained to perform MKTP. They use the same technique developed by MKTP pioneer Sanjeev Mulekar, M.D., of the National Vitiligo Center in Saudi Arabia.

MKTP is among multiple treatment options available at Henry Ford for treating vitiligo, which currently has no cure. These include topical medications, light therapy, depigmentation and skin grafting. Ideal candidates for MKTP are adults and children whose vitiligo patches have not increased in size and no new patches formed in at least six months.

The results of Henry Ford's research study, published online in August in the Journal of the American Academy of Dermatology, illustrate the potential of MKTP as a viable treatment option. Twenty-three patients regained on average 45 percent of their natural skin color. Ten patients with a specific type of vitiligo regained on average 65 percent of their skin color.

Dr. Hamzavi also says MKTP is "well-suited" for treating patients with burn-related injuries.

"MKTP provides a pigment reservoir where there is none and burn patients are ideal for this surgery because their immune system will not reject the transplanted skin cells," he says.

During MKTP, melanocyte cells, which produce pigment in the skin, hair and eyes, are harvested from an area of healthy skin and separated to make a skin cell mixture. This mixture then is applied to the treatment area and covered with a specially developed adhesive biologic dressing. MKTP allows dermatologists to treat the affected area up to 10 times the area of donor skin, Dr. Hamzavi says.

Pigmentation starts to return about two months after surgery and may take up to six months. For patients with fair skin, pigmentation may take longer. Some patients may require additional surgery or other treatment options to enhance their results.


'/>"/>
Contact: David Olejarz
dolejar1@hfhs.org
313-874-4094
Henry Ford Health System
Source:Eurekalert  

Related medicine news :

1. Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus
2. Henry Ford Hospital study shows link between vitamin D, skin cancer
3. Henry Ford Hospital study: Shoulder function not fully restored after surgery
4. Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer
5. Henry Ford Health System goes radical: Creating the hospital of the future
6. Henry Ford Hospital study: Less prep needed for colonoscopy
7. Henry Ford Hospital: New left-side heart pump improves right-side heart function
8. Henry Ford Hospital study: Fewer infections with new heart-pump implant
9. Henry Gabelnick receives lifetime achievement award
10. Sung-Cheng (Henry) Huang receives 2010 Benedict Cassen Prize for Research in Nuclear Medicine
11. Healthy U Chosen as Exclusive Concessions Provider for McHenry's 1st Annual Kicks 4 Kids Youth Charity Soccer Tournament
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Henry Ford Hospital first in United States to offer MKTP surgery as treatment option for vitiligo
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: